Baxter announces u.s. fda clearance of novum iq syringe infusion pump with dose iq safety software

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a leader in innovative technology for medication delivery, today announced u.s. food and drug administration (fda) 510(k) clearance of its new novum iq syringe infusion pump (syr) with dose iq safety software, representing baxter's latest developments for infusion therapy. the novum iq syr has the capability to fully integrate with hospital electronic medical records (emrs) through baxter's iq enterprise connectivity suite.
BAX Ratings Summary
BAX Quant Ranking